Erratum: Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma (Blood Cancer Discov (2022) 3 (385–393) DOI: 10.1158/2643-3230.BCD-21-0177)

N. Y. Saini, D. M. Swoboda, U. Greenbaum, J. Ma, R. D. Patel, K. Devashish

Research output: Contribution to journalComment/debate

Abstract

The editors are publishing this note to alert readers to a concern about this article (1). The corresponding author, Koichi Takahashi, informed the editors that the DNA sequencing data derived from samples collected from the 15 patients at the Moffitt Cancer Center were mislabeled, resulting in the genetic analyses for these patients’ samples not being matched to the correct patient of origin.

Original languageEnglish
Pages (from-to)246
Number of pages1
JournalBlood cancer discovery
Volume4
Issue number3
DOIs
StatePublished - 1 May 2023

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Erratum: Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma (Blood Cancer Discov (2022) 3 (385–393) DOI: 10.1158/2643-3230.BCD-21-0177)'. Together they form a unique fingerprint.

Cite this